Articles
-
6 habits for keeping your lab equipment in good shape
See what simple habits can have an outsized impact on the reliability and longevity of your lab equipment.
-
Achieving operational efficiency in today’s fragmented market
Improving bioprocess efficiency is key to succeeding in a fragmented market. Use the latest technologies and solutions to do it without sacrificing flexibility.
-
Amgen: Linking raw material data from suppliers to patients
By collaborating openly across the industry, we can minimize and control raw material risk and better manage our supply chain for the purpose of delivering the safest and most effective drugs possible.
-
Bacterial capsular polysaccharides
Purification platform for vaccine production
-
Best practices for a successful bioprocess technology transfer
A well-executed bioprocess technology transfer (tech transfer) is critical to ensure smooth knowledge transfer and optimal process reproducibility. If not executed properly, you risk reducing the quality and efficiency of your process.
-
Bioburden control
Addressing microbial contamination
-
Biopharma: Addressing talent crunch in a growing industry
Gaining a skilled labor force in the growing biopharma industry can be a challenge. So what strategies should your company be considering for recruiting, training and retaining qualified bioprocessing candidates.
-
Biopharma: How to win in emerging markets
Unexplored and emerging markets are an attractive prospect for biopharma companies looking to expand. But when it comes to ensuring success, what’s the wisest way to invest?
-
Bioreactor oxygen
Importance of aeration and ways to control kLa during cell cultivation
-
Building A Better Film For Single-Use Bioprocessing Through Effective Partnering
Choosing the right partner is key to addressing the challenges of implementing single-use technology.
-
Can a shared biomanufacturing facility be the answer?
With a shared biomanufacturing facility, you can mitigate the risks of demand uncertainty using a flexible solution that allows you to grow and change in the new paradigm of biomanufacturing.
-
Case study: virus reduction of an affinity capture step
This case study describes a successful viral clearance study for a protein A chromatography biomanufacturing step.
-
CDMO or no CDMO . . . that is the question
By checking the pulse of your organization first, it is possible to identify gaps and develop a plan for how to address them, so you can make the right decisions at the right time.
-
Cell culture titer and protein quality
How media composition can maximize protein yield and quality attributes
-
Column packing methods for MabSelect PrismA resin
Good column packing is essential for any chromatographic process. This procedure includes robust and verified packing and testing methods that will help eliminate concerns and risks associated with poorly packed beds.
-
Concentrated fed-batch
Intensify your process by going from cell vial to 2000 L bioreactor in 1 step
-
Continuous chromatography
PCC chromatography + straight-through processing = intensified
-
Developing a new biologic drug: regulatory challenges and considerations
Key milestones and planning ahead for compliance when bringing a new biologic drug to market.
-
Digital aids productivity and growth
Digital technologies can improve productivity and growth in cell therapy manufacturing and in bioprocessing.
-
Digital manufacturing of biologics
The recent explosion in monitoring, analytics and new computing capabilities initiated the revolution called digital biomanufacturing. Learn how it can help biomanufacturers to improve their manufacturing processes.
-
Digital transformation in biomanufacturing
Industry 4.0 uses digital connection and advanced analytics to improve bioprocess productivity. Digital transformation is how to get there. A GE and Biogen case study illustrates the value.
-
Doubling up for speed in biomanufacturing
Parallel operations affords the opportunity to develop a process in a parallel path using the resources of an external CDMO partner while simultaneously establishing your manufacturing capabilities.
-
Dry powdered medium milling equivalency study
Study compares powdered cell culture medium production using Sturtevant and Hosokawa pin mills. Physical, chemical, and biological data including cell growth.
-
Efficient and scalable buffer preparation
Two ways to use the quaternary valve of an ÄKTA avant chromatography system for buffer preparation – scale up to an inline conditioning system or scale down for robustness studies.
-
Efficient protein A chromatography for bispecific antibodies
Bispecific antibodies (BsAb) can be purified using protein A chromatography in only a single step. BsAb constructs were efficiently purified to give more than 90% purity and 85% yield in the early screening downstream process.
-
Fermentation
Which offers better process economy and production capacity: single-use or stainless?
-
Fiber-based protein A chromatography for HTPD
Study evaluates research-scale units and 96-well plates in applications for high-throughput monoclonal antibody purification.
-
Filtration
How to efficiently concentrate a low-titer antibody sample
-
Flavivirus vaccine
Accelerate production with modern tools and solutions
-
Flow and gradient accuracy using ÄKTA pilot 600 system
Accurate flow and gradient performance are important to provide reproducible chromatography results at different scales. In this study we investigated flow and gradient accuracy of the ÄKTA pilot 600 chromatography system.
-
Gain efficiency in process development
Learn how fellow scientists use ÄKTA avant to gain efficiency in protein purification process development
-
How the industrial internet of things is transforming Bioprocessing
Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data – maximizing efficiency from people, processes, equipment and core systems. How? By facilitating data driven decisions.
-
Integrating automation in a biomanufacturing environment
Integrating automation can become a daunting task without the right preparation and a clear implementation strategy. Through proper planning, you can eliminate costly errors and missteps.
-
Influenza vaccine
Production process using single-use bioprocessing equipment
-
Intensified chromatography strategies
Explore downstream operations to improve biomanufacturing productivity, speed, and flexibility. Options include improved resins, prepacked columns, continuous chromatography operations, and fiber-based chromatography.
-
Manufacturing of viral vectors
For use in gene therapy and development of therapeutic vaccines
-
Monoclonal antibodies
Intensify downstream processing of mAbs with innovative, integrated approaches
-
Overcome chromatography challenges with fiber adsorbents
Productivity of chromatography processes is limited by mass transfer and surface area of existing technologies. Fiber adsorbents address these challenges and support downstream process intensification efforts.
-
Next generation bioprocesses: Mapping roads to the future
Explore available options to select a path based on molecule and facility needs
-
Perfusion culture with ATF cell retention
Perfusion culture of an antibody-producing CHO cell line, with alternating tangential flow filtration (ATF) for cell retention. Uses an XDR-10 bioreactor system, hollow fiber filter cartridge, and diaphragm pump.
-
Perfusion culture with TFF cell retention
Perfusion culture of an antibody-producing CHO cell line, with tangential flow filtration (TFF) for cell retention. Uses an XDR-10 bioreactor system and hollow fiber filter cartridge as cell retention device.
-
Preparing for the future of biomanufacturing
New market dynamics are reshaping how biologics are produced and sold. Here’s what six industry experts say about the way forward.
-
Purposeful design and development of a next-generation single-use bioprocess film
Biomanufacturing requires a film technology specifically designed for working with biologics.
-
Raw material variability: the need for deeper process understanding
The importance of resin variability characterization for obtaining robust chromatography polishing processes
-
Resin slurry concentration
Accurate determination for optimal column performance
-
Risk assessment: when to study chromatography resin variability
How do you identify which parameters and interactions to focus on in your process characterization studies?
-
Sanitization: AxiChrom columns
Peracetic acid (PAA) was evaluated as sanitization agent in the packing and repacking of a protein A resin in AxiChrom 300 column.
-
Sanitization of the ÄKTA pilot 600 chromatography system
In this study we evaluated the predefined sanitization methods for the ÄKTA pilot 600 chromatography system. E. coli and yeast were used as challenging organisms and NaOH as sanitization solution.
-
Scaling a mAb production process to Xcellerex bioreactors
Moving a monoclonal antibody production process from a microscale bioreactor to the Xcellerex XDR single-use platform
-
Single-use chromatography
Adapting to manufacturing scale
-
Suppliers' contributions to bioprocessing advances
From platform processes to disruptive technologies: The future of innovation continues.
-
Securing bioprocess film supply
Transparency across the single-use film supply chain helps to ensure security of supply for single-use bags.
-
The antibody boom
Antibodies continue to dominate the biopharma market. Analyzing the strategies employed by successful players in the field could provide invaluable lessons for those hoping to enter it.
-
The good and bad of biosimilars
The biosimilars market is suddenly booming, with established biopharma giants and nimble start-ups all clamoring for a piece of the action. But such steep competition means that only the wise will survive.
-
The transparent CDMO
Handing over vital information about your product can be very unnerving. That is why it is important to find a CDMO who can help alleviate drug development risks and protect your intellectual property (IP).
-
Understanding and controlling raw material variation in cell culture media
Manage variability through advanced analytical methods and risk-based assessment
-
Vaccines
Accelerate cell-based vaccine production with modern tools and solutions
-
Vaccines: A balancing act
Although absolutely crucial for maintaining global health, vaccines are challenging to develop and manufacture. How can businesses ensure profitability while maintaining low prices for developing countries?
-
Viral clearance study basics
Effective viral clearance studies remain one of the challenges facing manufacturers of biologics. Here is an overview of the fundamentals of viral clearance studies related to the chromatography steps in a bioprocess.
-
Multidimensional scale-up using ÄKTA pilot 600 system
In this study we demonstrate a 20-fold multidimensional mAb capture step scale-up. Read how equivalent mAb recovery and purity was achieved between the larger and smaller scales using an ÄKTA pilot 600 chromatography system.
-
Scalable ADCF virus production using HyClone VaccineXpress medium
HyClone VaccineXpress cell culture medium promotes the production of infective influenza virus and rotavirus in a scalable ADCF process.
-
Studying resin variability using a Process Characterization Kit
Learn how Process Characterization Kits can be used to assess the potential impact of resin ligand density variability on product quality and process performance.
Tools
Webinars
Videos
-
5 key considerations for creating cGMP single-use biomanufacturing capacity
-
500 L single-use Xcellerex microbial fermentor
-
Fortem single-use platform film built for bioprocessing
-
KUBio: The proven response for rapid biomanufacturing
-
ReadyToProcess prepacked, validated columns
-
Rehydrating powder media with Xcellerex mixers
-
Single-use TFF system: ÄKTA readyflux
-
Visit GE Healthcare Life Sciences YouTube Library